People · Operator
Named in public records as an officer, director or promoter · active 2011–2020 · Biotech / Pharma, Other Energy
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Manus Bio Inc. | — | Biotech / Pharma | Series C | $118.0M | $108.4M | 2016 |
| Novogy, Inc. | — | Other Energy | Series A | $14.8M | $21.1M | 2011 |
Gregory Stephanopoulos at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gregory Stephanopoulos on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Raymond Chang | 1 | 10 |
| David Orfao | 1 | 10 |
| Jeff Anderson | 1 | 8 |
| Andrew Ziolkowski | 1 | 5 |
| Richard Goldstein | 1 | 5 |
| Carsten Boers | 1 | 5 |
| COLIN GOUNDEN | 1 | 4 |
| Jason Whaley | 1 | 4 |
| Rick Gerson | 1 | 2 |
| Michael A. Carlos | 1 | 1 |
| Jean A. Nehme | 1 | 1 |
| John Nehme | 1 | 1 |
| Michael Carlos | 1 | 1 |
| Jeremiah Hux | 1 | 1 |
| Ajikumar Parayil | 1 | 1 |
| Alena Ivashenka | 1 | 1 |
| Zanna McFerson | 1 | 1 |
| Bryon Alsberg | 1 | 1 |
| Christine Santos | 1 | 1 |
| Paul Boni | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.